Skip to content
Screener

GoodRx Holdings, Inc. GDRX Sales & Marketing

Sales & Marketing at other companies

Amazon logo
AmazonAMZN
$11.7B+2.5%
OptimizeRx logo
OptimizeRxOPRX
$4.73M-5.1%
Doximity logo
DoximityDOCS
$45.05M+23.9%
Progyny logo
ProgynyPGNY
$18.07M-1.8%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$29.87M+34.1%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$262.24M+20.4%

Segments

By product

See full
Prescription transactions revenue$0

Other financials

Income statement

See full
Revenue$200.4M-1.3%
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
Operating cash flow$80.8M+63.0%
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation

See full
Market cap$1.26B+3.8%
Enterprise value$1.5B+1.6%
P/E77.3×+42.3×
P/S1.6×+0.1×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001809519-26-000152
(in thousands, except for per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Costs and operating expenses:
Cost of revenue, exclusive of depreciation and amortization presented separately below20,99913,35041,15526,714
Product development and technology26,71129,93356,88861,075
Sales and marketing81,98684,870163,039169,412
General and administrative24,81428,37951,63358,009
Depreciation and amortization22,26919,72944,06140,641
Total costs and operating expenses176,779176,261356,776355,851
Operating income23,63226,80937,64150,189

Item 1. Financial Statements

FAQ

What is GoodRx Holdings, Inc.'s sales & marketing?
GoodRx Holdings, Inc. (GDRX) reported sales & marketing of $81.99M in Q2 2026.
How has GoodRx Holdings, Inc.'s sales & marketing changed year-over-year?
GoodRx Holdings, Inc.'s sales & marketing decreased by 3.4% year-over-year, from $84.87M to $81.99M.
What is the long-term trend for GoodRx Holdings, Inc.'s sales & marketing?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s sales & marketing has grown at a -2.7% compound annual growth rate (CAGR), from $370.22M to $331.56M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.

Ask your AI about GoodRx Holdings, Inc.'s sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude